Skip to main content
Powered by ShareScore

Find research datasets worth reusing

Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.

36

datasets available to search

ShareScore release 0.9.0

Reset

Dataset results

36 results for “toxic risk”

Learn how ShareScore rates datasets ↗
zenodo40/100

Verzehrsstudie zur Ermittlung der Lebensmittelaufnahme von Säuglingen und Kleinkindern für die Abschätzung eines akuten Toxizitätsrisikos durch Rückstände von Pflanzenschutzmitteln (VELS) [Consumption study to determine the food intake of infants and young children for the estimation of an acute toxicity risk through residues of plant protection products]

<p>The VELS study (<strong>V</strong>erzehrsstudie zur <strong>E</strong>rmittlung der Lebensmittelaufnahme von <strong>S</strong>&auml;uglingen und Kleinkindern f&uuml;r die Absch&auml;tzung eines akuten Toxizit&auml;tsrisikos durch R&uuml;ckst&auml;nde von Pflanzenschutzmitteln; VELS) was conducted in 2001/2002. Data were collected from 804 infants, toddlers and children (age group 0.5 to &lt;5 years) in Germany. The food consumed was recorded by the parents as &quot;food as eaten&quot; over a total of 6 days (2x3-day food record with an interval of 3-6 months for toddlers and 4-8 weeks for infants). Anthropometric data are also included.</p> <p>Foods are coded according to the German food coding system (BLS; Bundeslebensmittelschl&uuml;ssel) and food names and additional information is available in German only.</p> <p>Dataset owner: German Federal Institute for Risk Assessment (BfR)</p> <p>Data collection was carried out by the University of Paderborn on behalf of the Federal Ministry of Food and Agriculture [Bundesministerium f&uuml;r Ern&auml;hrung und Landwirtschaft; BMEL] &ndash; formerly Federal Ministry for Food, Agriculture and Consumer Protection [Bundesministerium f&uuml;r Verbraucherschutz, Ern&auml;hrung und Landwirtschaft; BMVEL]</p>

opencc-by-nc-4.0Sep 2023View details →
dryad36/100

Data from: Larger frogs are better mimics but are more risk-averse in a non-toxic poison frog

Open the record for dataset details and reuse information.

publicSep 2025View details →
dryad36/100

An advancement in developmental and reproductive toxicity (DART) risk assessment: evaluation of a bioactivity and exposure-based NAM toolbox

Open the record for dataset details and reuse information.

publicAug 2025View details →
zenodo32/100

Identifying in vitro toxicity testing approaches for (novel) proteins in the context of food and feed risk assessment

<p>Annexes to EFSA external scientific report Identifying <em>in vitro</em> toxicity testing approaches for (novel) proteins in the context of food and feed risk assessment</p>

opencc-by-4.0Nov 2024View details →
ClinicalTrials.gov32/100

Trial Comparing Prone and Supine Intensity-modulated Radiotherapy (IMRT) After Breast-conserving Surgery in Patients With Large Breast Volume at High Risk for Skin Toxicity and Fibrosis

ClinicalTrials.gov study NCT00887523. IPD Sharing: Not stated. Countries: 1. Publications: 1.

restrictedIPD-UNDECIDEDFeb 2026View details →
ClinicalTrials.gov32/100

Cardiovascular Morbidity in Testicular Cancer Survivors: Study of Risk Factors and Assessment of Pharmacogenomic Determinants of Toxicity

ClinicalTrials.gov study NCT00161174. IPD Sharing: Not stated. Countries: 1. Publications: 52.

restrictedIPD-UNDECIDEDFeb 2026View details →
ClinicalTrials.gov32/100

Study Evaluating Impact of IL-7 on CD4 Lymphopenia, Risks of Severe Haematological Toxicity and Tumor Progression in Metastatic Breast Cancer Patients

ClinicalTrials.gov study NCT01368107. IPD Sharing: Not stated. Countries: 1. Publications: 28.

restrictedIPD-UNDECIDEDFeb 2026View details →
ClinicalTrials.gov32/100

JOint Use of Database to Identify Risk Factors of CARDio-vascular Toxicity Induced by Immune Checkpoint Inhibitors

ClinicalTrials.gov study NCT04294771. IPD Sharing: NO. Countries: 1. Publications: 7.

closedIPD-NOFeb 2026View details →
ClinicalTrials.gov32/100

Cardiovascular Toxicity Induced by Antitumoral Drugs: Risk Assessment and Early Diagnosis. CARDIOTOX Registry

ClinicalTrials.gov study NCT02039622. IPD Sharing: Not stated. Countries: 1. Publications: 1.

restrictedIPD-UNDECIDEDFeb 2026View details →
ClinicalTrials.gov32/100

Thal-Fabs: Reduced Toxicity Conditioning for High Risk Thalassemia

ClinicalTrials.gov study NCT05426252. IPD Sharing: NO. Countries: 1. Publications: 1.

closedIPD-NOFeb 2026View details →
ClinicalTrials.gov32/100

Reduced Toxicity Conditioning Prior to Unrelated Cord Cell Transplantation for High Risk Myeloid Malignancies

ClinicalTrials.gov study NCT02333838. IPD Sharing: Not stated. Countries: 1. Publications: 4.

restrictedIPD-UNDECIDEDFeb 2026View details →
ClinicalTrials.gov32/100

Clinical Trial to Assess the Efficacy and Toxicity of Induction and Consolidation With CPX-351 for Patients Aged 60 to 75 Years With Secondary or High-risk Acute Myeloid Leukemia

ClinicalTrials.gov study NCT04230239. IPD Sharing: NO. Countries: 1. Publications: 14.

closedIPD-NOFeb 2026View details →
ClinicalTrials.gov32/100

Risk Factors of Immune-ChEckpoint Inhibitors MEdiated Liver, Gastrointestinal, Endocrine and Skin Toxicity

ClinicalTrials.gov study NCT04631731. IPD Sharing: UNDECIDED. Countries: 1. Publications: 4.

restrictedIPD-UNDECIDEDFeb 2026View details →
ClinicalTrials.gov32/100

S1501 Dual Observational and Randomized Cohort Study of Patients With Metastatic HER-2+ Breast Cancer at Risk of Cardiac Toxicity

ClinicalTrials.gov study NCT03418961. IPD Sharing: Not stated. Countries: 4. Publications: 1.

restrictedIPD-UNDECIDEDFeb 2026View details →
dryad32/100

Advancing systemic toxicity risk assessment: Evaluation of a NAM-based toolbox approach

Open the record for dataset details and reuse information.

publicApr 2025View details →
dryad28/100

Data from: Identification of candidate risk factor genes for human idelalisib toxicity using a collaborative cross approach

Idelalisib is a phosphatidylinositol 3-kinase inhibitor highly selective for the delta isoform that has shown good efficacy in treating chronic lymphocytic leukemia and follicular lymphoma. In clinical trials, however, idelalisib was associated with rare, but potentially serious liver and lung toxicities. In this study, we used the Collaborative Cross (CC) mouse population to identify genetic factors associated with the drug response that may inform risk management strategies for idelalisib in humans. Eight (8) male mice (4 matched pairs) from 50 CC lines were treated once daily for 14 days by oral gavage with either vehicle or idelalisib at a dose selected to achieve clinically-relevant peak plasma concentrations (150 mg/kg/day). The drug was well tolerated across all CC lines, and there were no observations of overt liver injury. Differences across CC lines were seen in drug concentration in plasma samples collected at the approximate Tmax on study Days 1, 7, and 14. There were also small but statistically significant treatment-induced alterations in plasma total bile acids and microRNA-122, and these may indicate early hepatocellular stress required for immune-mediated hepatotoxicity in humans. Idelalisib treatment further induced significant elevations in the total cell count of terminal bronchoalveolar lavage fluid, which may be analogous to pneumonitis observed in the clinic. Genetic mapping identified loci associated with interim plasma idelalisib concentration and the other three treatment-related endpoints. Thirteen (13) priority candidate quantitative trait genes identified in CC mice may now guide interrogation of risk factors for adverse drug responses associated with idelalisib in humans.

opencc-zeroSep 2020View details →
ClinicalTrials.gov28/100

EMR Chemotoxicity Risk Calculator To Decrease Chemotherapy Toxicity

ClinicalTrials.gov study NCT05809557. IPD Sharing: NO. Countries: 1. Publications: 0.

closedIPD-NOFeb 2026View details →
ClinicalTrials.gov28/100

Stem Cell Transplantation To Treat High Risk Multiple Myeloma With Reduced Toxicity Myeloablative Conditioning Regimen

ClinicalTrials.gov study NCT00615589. IPD Sharing: Not stated. Countries: 1. Publications: 0.

restrictedIPD-UNDECIDEDFeb 2026View details →
ClinicalTrials.gov28/100

Wearable Technology and Machine Learning for Early Detection and Risk Assessment of Unacceptable Toxicities in a Paediatric Oncology Cohort

ClinicalTrials.gov study NCT07030998. IPD Sharing: YES. Countries: 1. Publications: 0.

controlledIPD-YESFeb 2026View details →
dryad28/100

Data from: Identification of candidate risk factor genes for human idelalisib toxicity using a collaborative cross approach

Open the record for dataset details and reuse information.

publicSep 2019View details →

ScienceDex guides

Understand access before you commit

These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.

Compare curated datasets

Allen Brain Atlas

Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.

allen-brain-atlas
neuroscienceopenDocumentation, web resources, and API references are available online.
Last verified 2026-04-30Open record

Annotated Behaviour and Observability Dataset (ABODe)

ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.

abode-home-cage
behavioral-neuroscienceopenThe DataShare record exposes download links for annotations, documentation, license text, and the zipped per-snippet data directory.
Last verified 2026-04-30Open record

DANDI Archive for NWB datasets

DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.

dandi-nwb
electrophysiologyopenPublished Dandiset metadata and archive endpoints are available through the production DANDI API.
Last verified 2026-04-30Open record

International Brain Laboratory public data

The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.

ibl
behavioral-neuroscienceopenPublic sessions can be searched and loaded from the IBL public data server through ONE.
Last verified 2026-04-29Open record

OpenNeuro

OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.

openneuro
neuroscienceopenPublished datasets are available on demand over the internet.
Last verified 2026-04-29Open record